Matrix Metalloproteinase Inhibition Reduces Contraction by Dupuytren Fibroblasts

Journal of Hand Surgery

Volumn 33, Issue 9, 2008, Pages 1608-1616

  Townley, William A ^a   Cambrey, Alison D ^a   Khaw, Peng T ^a   Grobbelaar, Adriaan O ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Dupuytren; ilomastat; MMP; recurrent contracture

Indexed keywords

GELATINASE A; ILOMASTAT; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DUPUYTREN CONTRACTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGED; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; COLLAGEN; DUPUYTREN'S CONTRACTURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; INDOLES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; UP-REGULATION;

EID: 54949107022     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2008.06.013     Document Type: Article

References (39)

1. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., and Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3 (2002) 349-363
2. Rodrigo J.J., Niebauer J.J., Brown R.L., and Doyle J.R. Treatment of Dupuytren's contracture. Long-term results after fasciotomy and fascial excision. J Bone Joint Surg 58A (1976) 380-387
3. Badalamente M.A., Hurst L.C., and Hentz V.R. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg 27A (2002) 788-798
4. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
5. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69 (2006) 562-573
6. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270 (1995) 5331-5338
7. Ravanti L., and Kahari V.M. Matrix metalloproteinases in wound repair. (review). Int J Mol Med 6 (2000) 391-407
8. Zucker S., and Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23 (2004) 101-117
9. Tchetverikov I., Ronday H.K., Van El B., Kiers G.H., Verzijl N., TeKoppele J.M., et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63 (2004) 881-883
10. Tayebjee M.H., Lip G.Y., and MacFadyen R.J. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. Curr Med Chem 12 (2005) 917-925
11. Vernooy J.H., Lindeman J.H., Jacobs J.A., Hanemaaijer R., and Wouters E.F. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 126 (2004) 1802-1810
12. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
13. Mengshol J.A., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?. Arthritis Rheum 46 (2002) 13-20
14. Tarlton J.F., Meagher P., Brown R.A., McGrouther D.A., Bailey A.J., and Afoke A. Mechanical stress in vitro induces increased expression of MMPs 2 and 9 in excised Dupuytren's disease tissue. J Hand Surg 23B (1998) 297-302
15. Ulrich D., Hrynyschyn K., and Pallua N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plast Reconstr Surg 112 (2003) 1279-1286
16. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13 (2003) 264-269
17. Sheridan C.M., Occleston N.L., Hiscott P., Kon C.H., Khaw P.T., and Grierson I. Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue. Am J Pathol 159 (2001) 1555-1566
18. Daniels J.T., Cambrey A.D., Occleston N.L., Garrett Q., Tarnuzzer R.W., Schultz G.S., et al. Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci 44 (2003) 1104-1110
19. Pins G.D., Collins-Pavao M.E., Van De Water L., Yarmush M.L., and Morgan J.R. Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. J Invest Dermatol 114 (2000) 647-653
20. Scott K.A., Wood E.J., and Karran E.H. A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction. FEBS Lett 441 (1998) 137-140
21. Wong T.T., Mead A.L., and Khaw P.T. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 44 (2003) 1097-1103
22. Bisson M.A., McGrouther D.A., Mudera V., and Grobbelaar A.O. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg 28B (2003) 351-356
23. Stephens P., Davies K.J., Occleston N., Pleass R.D., Kon C., Daniels J., et al. Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol 144 (2001) 229-237
24. Bisson M.A., Mudera V., McGrouther D.A., and Grobbelaar A.O. The contractile properties and responses to tensional loading of Dupuytren's disease-derived fibroblasts are altered: a cause of the contracture?. Plast Reconstr Surg 113 (2004) 611-621 discussion 622-614
25. Brickley-Parsons D., Glimcher M.J., Smith R.J., Albin R., and Adams J.P. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg 63A (1981) 787-797
26. Alioto R.J., Rosier R.N., Burton R.I., and Puzas J.E. Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. J Hand Surg 19A (1994) 442-452
27. Luck J.V. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg 41A (1959) 635-664
28. Vande Berg J.S., Gelberman R.H., Rudolph R., Johnson D., and Sicurello P. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord). J Orthop Res 2 (1984) 247-256
29. Moyer K.E., Banducci D.R., Graham III W.P., and Ehrlich H.P. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro. Plast Reconstr Surg 110 (2002) 187-193 discussion 194-186
30. Derderian C.A., Bastidas N., Lerman O.Z., Bhatt K.A., Lin S.E., Voss J., et al. Mechanical strain alters gene expression in an in vitro model of hypertrophic scarring. Ann Plast Surg 55 (2005) 69-75 discussion 75
31. Johnston P., Chojnowski A.J., Davidson R.K., Riley G.P., Donell S.T., and Clark I.M. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease. J Hand Surg 32A (2007) 343-351
32. Augoff K., Ratajczak K., Gosk J., Tabola R., and Rutowski R. Gelatinase A activity in Dupuytren's disease. J Hand Surg 31A (2006) 1635-1639
33. Mudera V.C., Pleass R., Eastwood M., Tarnuzzer R., Schultz G., Khaw P., et al. Molecular responses of human dermal fibroblasts to dual cues: contact guidance and mechanical load. Cell Motil Cytoskeleton 45 (2000) 1-9
34. Ritty T.M., and Herzog J. Tendon cells produce gelatinases in response to type I collagen attachment. J Orthop Res 21 (2003) 442-450
35. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., et al. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263 (2001) 209-223
36. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 (2003) 827-839
37. Fitzgerald A.M., Kirkpatrick J.J., and Naylor I.L. Dupuytren's disease. The way forward?. J Hand Surg 24B (1999) 395-399
38. Fujiwara M., Muragaki Y., and Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 153 (2005) 295-300
39. White J.M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15 (2003) 598-606